AI-accelerated protocol creation, feasibility, and alignment.
faster trial preparation
AI-accelerated protocol creation, feasibility, and alignment.
saved per avoided amendment
AI-accelerated protocol creation, feasibility, and alignment.
clinical trials
trained on
The current situation
Solving AI's Opacity Problem
Clinical teams face an impossible choice: use AI that speeds up processes but can't be explained to regulators, or stick with manual methods that guarantee delays.
70% of trials are delayed
Regulators demand clear justification for every decision
$400K+ per amendment
60% require costly protocol amendments
The new standard
Finally, AI you can actually explain
Aika is the first AI-native platform designed to accelerate clinical trial setup and reduce risk by integrating protocol design, feasibility, and regulatory planning.
Achieve more with Aika
Complete documentation
Every suggestion comes with full justification showing exactly how Aika reached its recommendation. Present your choices to regulators with confidence.
Competitive landscape clarity
See what similar trials are doing, identify gaps in the market, and understand where opportunities exist in your therapeutic area.
Seamless workflow integration
Work the way you always have. Aika enhances your process without requiring new systems or extensive team training.
The impact on your work
Faster patient access
Accelerate your timeline by 3-6 months by eliminating research bottlenecks and designing trials that work from the start.
Cost and time control
Save $500K-$1M+ per trial while dramatically reducing the months typically lost to rework cycles and regulatory delays.
Regulatory confidence
Walk into meetings knowing you can defend every decision with specific evidence from comparable successful trials.
Strategic advantage
Make informed choices in hours, not weeks, while competitors struggle with manual research and internal limitations.
Metric
The Old Way
Testimonials
Trusted by Leaders. Backed by Science.
Trained on 560,000+ clinical trials.
“Biorce is exactly the kind of pioneering company we’re here to back. They’re combining deep sector expertise with cutting-edge AI to solve what truly matters. Their platform has the potential to radically reduce both the time and cost of bringing new treatments to market, unlocking huge value for pharma and, more importantly, faster access to life-saving therapies for patients.”
Tove Larsson
General Partner | Norrsken VC
Used across US, EU & APAC by global clinical trial teams.
"The expansive potential of Jarvis hints at a wealth of untapped applications beyond drugs development; it opens the door to evolutionary possibilities that could help redefine efficiency and precision in the broader medical field"
Ricardo Matias
CRIO | Co-Founder of Kinetikos
Built by former CRO, clinicians, regulatory, and AI leaders.
$5M invested by Norrsken, Europe’s leading impact VC to reinvent clinical trials.
"I think this is a fantastic tool for clinical trialists that will not only save time but could potentially reduce the number of avoidable protocol amendments, saving costs and enhancing confidence in evaluation of the study objectives"
Laurence Skillern
Medical Director | CMO of ISTESSO
